Home › NDC Lookup › RxCUI directory › RxCUI 849928

Caffeine citrate 20 MG/ML Oral Solution — RxCUI 849928

RxNorm drug concept · Semantic clinical drug
RxCUI 849928 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI849928
Official nameCaffeine citrate 20 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascaffeine citrate 60 MG per 3 ML Oral Solution; caffeine citrate 60 MG in 3 mL Oral Solution
FDA products mapped8
Package NDCs mapped9
Reported Medicaid activity (SDUD)220 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Caffeine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Caffeine citrate is a prescription medicine given in the hospital to premature babies who have apnea of prematurity — that means they sometimes stop breathing for short periods, wh...
  • What exactly is caffeine citrate used for in babies, and is it safe?
  • The medical team will be monitoring your baby closely, but it helps to know the signs to watch for. The most serious concern is necrotizing enterocolitis (NEC) — a severe intestina...
  • What side effects should I watch for in my premature baby on caffeine citrate?
📖 Read our full Caffeine guide →

🕸️ Concept Web — How Caffeine citrate 20 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Caffeine citrate 20 MG/ML Oral Solution RxCUI 849928

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Caffeine 1886
    • Caffeine citrate 20033
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Caffeine Oral Solution 371183
    • Caffeine citrate Oral Solution 2645817
    • Caffeine Oral Liquid Product 1152688
    • Caffeine Oral Product 1152689
    • Caffeine citrate Oral Liquid Product 2660064
    • Caffeine citrate Oral Product 2659773
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Caffeine citrate 20 MG/ML 849927

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Caffeine citrate 20 MG/ML SCDC · 849927
  • Caffeine Oral Solution SCDF · 371183
  • Caffeine citrate Oral Solution SCDFP · 2645817
  • Caffeine Oral Liquid Product SCDG · 1152688
  • Caffeine Oral Product SCDG · 1152689
  • Caffeine citrate Oral Liquid Product SCDGP · 2660064
  • Caffeine citrate Oral Product SCDGP · 2659773

📦 FDA Products & Package NDCs

8 products · 9 package NDCs
9 package NDCs map to RxCUI 849928 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
25021-0601-03 1 VIAL in 1 CARTON (25021-601-03) / 3 mL in 1 VIAL caffeine citrate Sagent Pharmaceuticals 2012-09-15
25021-0602-03 10 VIAL in 1 CARTON (25021-602-03) / 3 mL in 1 VIAL caffeine citrate Sagent Pharmaceuticals 2012-09-15
42571-0346-69 10 VIAL in 1 BOX (42571-346-69) / 3 mL in 1 VIAL Caffeine Citrate Micro Labs Limited 2020-02-01
47335-0289-27 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-289-27) / 3 mL in 1... Caffeine Citrate Sun Pharmaceutical Industries, Inc. 2014-06-05
47335-0290-44 10 VIAL, SINGLE-DOSE in 1 CONTAINER (47335-290-44) / 3 mL i... Caffeine Citrate Sun Pharmaceutical Industries, Inc. 2021-03-01
51754-0501-02 5 VIAL in 1 CARTON (51754-0501-2) / 3 mL in 1 VIAL caffeine citrate Exela Pharma Sciences, LLC 2019-08-31
51754-0501-03 10 VIAL in 1 CARTON (51754-0501-3) / 3 mL in 1 VIAL caffeine citrate Exela Pharma Sciences, LLC 2015-03-30
63323-0406-03 5 VIAL in 1 CARTON (63323-406-03) / 3 mL in 1 VIAL (63323-4... Caffeine Citrate Fresenius Kabi USA, LLC 2009-11-19
72485-0110-10 10 VIAL, SINGLE-DOSE in 1 BOX (72485-110-10) / 3 mL in 1 VI... Caffeine Citrate Oral Solution Armas Pharmaceuticals Inc. 2020-03-01
Observed labelers: Exela Pharma Sciences, LLC (2) · Sagent Pharmaceuticals (2) · Sun Pharmaceutical Industries, Inc. (2) · Armas Pharmaceuticals Inc. (1) · Fresenius Kabi USA, LLC (1) · Micro Labs Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.